Summun-In a cohort of women aged 40-64 at entry. 12 h urine samples were obtained at the beginning of a follow-up period of up to 15 years in which incident cases of lung cancer were registered as well as deaths from lung cancer. In this cohort a nested case-control study (n = 397) was carried out by measuring urinary cotinine. The method for quantitation of cotinine was sensitive enough to study lung cancer risk not only in active smokers but also in passive smokers. The results seem to indicate that cotinine estimations in singJe 12 h "mnlec-of iurine nre enoiah to nredirt tlne "ncrr ricsk Relative riKk rnqce with inerecit1n levelsk of nientine
trieved from the cancer registry. and two controls per case were selected by computer for comparison. Urine samples retrieved in the second and third waves were analysed in 1992.
Thus, the material for biochemical analysis consisted of urine samples from 92 lung cancer cases and 305 controls among two populations of women at risk of lung cancer over the years 1977-91 and 1988 -91. Anal) tical method At the National Institute of Public Health and Environmental Protection, Bilthoven (The Netherlands) urine concentrations of cotinine were measured by a capilllary gas chromatography-mass spectrometry (GC-MS) method. In brief the method of analysis was as described below.
To a 5 ml aliquot of urine, I ml of I mol I-1 sodium hydroxide and 1 Lg of internal standard (100 pl to a 10 ng ld' solution) were added and the mixture was transferred to an octadecyl (C 18) silica solid-phase extraction column, which was preconditioned with 1 ml of methanol and 1 ml of sodium borate buffer (0.05 mol 1-1; pH 9.0). 0.5-250ngml-' and 250-2500 ngml-') were constructed by plotting the peak height ratios (cotinine-cotinine-d3; ions 176:179) against the cotinine concentrations.
The limit of detection was 0.5 ng ml-'. The between-days variability for the concentration range 0.5-30ngml-l was 20-40%, depending on the concentration (n = 10). The between-days variability at a level of 100ngml-' cotinine was 10% (n= 10). In all analyses subjects with unreported cigarette consumption were excluded.
Results
Urinary excretion of cotinine according to declared smoking habits The frequency distributions of urinary logarithmically transformed urinary cotimnne concentrations of all women (controls plus cases) according to their declared smoking status at the time of urine collection are shown in Figure 1 . Clearly there exists a high degree of association between their selfreported smoking status and the objective tests of cotinine excretion.
Comparing the distribution of urinary cotimne concentrations with declared smoking status (Figure 1 ) indicated that the optimal cut-off point for distinguishing between active smokers on the one hand and passive smokers and nonsmokers on the other hand was at a level of 70 ng ml-' (log,0 70 being 1.85).
In order to allow for the influence of diuresis we have expressed the cotinine results not only as concentrations per ml of urine but also in the form of ratios on a creatinine basis. The correlation between both ways of expressing results is high (r = 0.97. 95% CI 0.96-0.97). The best cut-off point between smokers and non-smokers proved to be 100 ng mg-' of creatinine with a sensitivity of 91% and a specificity of 97% (questionnaire data acting as golden standard).
From a sample of 167 women (those representing the first wave of cases and controls: see Methods) cotinine has been measured in urine collected at two different points over time. with a 1 year interval. The Pearson correlation coefficient of the relation between the two samples concerning log cotimnne (in ng mg' creatinine) proved to be high (r = 0.88, 95% CI 0.83-0.91); above the level of 100 ng mg-' creatinine it was 0.79 (95% CI 0.62-0.89). below that level it was 0.49 (95% CI 0.32-0.64).
Cotinine excretion and lung cancer risk In investigating the relationship between the urinary excretion of cotinine and lung cancer risk a breakdown of exposures has been chosen so as to allow the study of lung cancer risk not only among active smokers but also among passive smokers. Thus three levels below 100 ng cotinine per mg creatinme and three levels above that point were distinguished. The results are shown in Tables I and II . The data show a clear trend of increasing lung cancer risk with rising cotinine excretion. The increased risk also appears to begin at levels of nicotine intake in the passive smoking range (Table  II) Table   III ). Relative risk in relation to cotimine excretion was computed separately for adenocarcinoma in contrast to the sum of other histological types. The results presented in Table IV show that the relationship with smoking is much weaker for adenocarcinoma of the lung than for the other pulmonary cancers. In fact, an odds ratio significantly above 1 was found only at fairly high levels of nicotine intake.
Discussion
This is believed to be among the first studies of its kind to establish a relationship between exposure to tobacco smoke and lung cancer risk by direct and objective methods, i.e. measuring cotinine in urinary samples from a cohort of women followed for a period of up to 15 years. The results confirm recent insight that lung cancer risk ratios according to amount smoked are equally high in women as in men Stellman. 1988: Osann et al., 1993 (Table II) . It is more in line with the relatively high estimates published by Garfinkel et al. (1985) . Pershagen et al. (1987) and some of the papers mentioned by Blot and Fraumeni (1986) . With our GC-MS method. cotimine excretion measurements were slightly higher than those reported by some others (Jarvis et al.. 1984; Wald et al., 1984; Wall et al., 1988; Haley et al., 1989) . However, they were much lower than those reported by Matsukura et al. (1984) . It should be borne in mind that excretion levels corrected for creatinine excretion are affected by gender since women have less muscle mass then men.
The question could be raised whether cotinine levels reflect passive smoking (Idle, 1984) . However. Jarvis et al. (1984 ( ), Wald et al. (1984 , Haley et al. (1989) . Riboli et al. (1990) and Cook et al. (1994) have shown that in non-smokers elevated cotinine levels are directly related to an increased environmental exposure to tobacco smoke. In a recent study Hecht et al. (1993) found a high correlation between urinary cotinine and a powerful tobacco-specific lung carcinogen. There is no reason to believe that the women were lying about their smoking habits when they were visiting the screening facility in good health. Biochemical errors are unlikely since the method of cotinine determination is very specific. We rule out any genetic traits to produce cotinine naturally. Theoretically, cotinine excretion due to the consumption of vegetables could complicate the interpretation of our study. However, cotinine exposure from vegetables is greatly reduced when vegetable skins, which contain most of the nicotine, are not eaten or cooked in water, thereby extracting the nicotine. Moreover, absorption of nicotine from the stomach is poor and 70% of it is metabolised during its first pass through the liver (Henningfield, 1993) . Thus the most likely explanation of low levels of urinary cotinine is exposure to environmental tobacco smoke.
Since cotimnne excretion levels obtained at intake in the cohort correlated well with those obtained 1 year later, there is objective evidence for the notion that these levels reflect the chronic smoking habits of the persons concerned and the relative constancy of levels of tobacco smoke in their immediate human environment. Jarvis et al. (1987) came to a similar conclusion after studying cotinine in saliva. It was shown by an independent laboratory that cotinine in the unnary samples of our 'bank' (which were kept frozen at -20°C) did not deteriorate over a period of 9 years (Riboli et al., 1995).
In our study, urinary cotinine did not seem to be more predictive of lung cancer, than self-reported cigarette consumption. This was not surprising since the urine samples and data about reported cigarette comsumption were collected before the risk of smoking in women became an important issue, and therefore probably very reliable. Unfortunately, no information was solicited concerning selfreported passive smoke exposure since data from the questionnaires were collected long before the first papers on that issue were published. So. it was not possible to study whether cotinine is more predictive of lung cancer risk than selfreported passive smoke exposure. However, there is an advantage of having an objective test of exposure to tobacco smoke instead of a questionnaire about hours of passive smoke exposure in non-smokers.
The present paper confirms results published by others (Kreyberg, 1954; Trichopoulos et al.. 1981; Damber and Larson, 1986; Koo et al.. 1987; Pershagen et al.. 1987; Osann, 1991; Brownson et al., 1992) on the relationship between smoking and adenocarcinoma of the lung; it is much weaker than that of other histological types. In fact, no relationship between adenocarcinoma and passive smoking was apparent from the data. The relatively high proportion of adenocarcinoma found in this cohort is in agreement with the relatively low percentage of smokers (30); the smokingrelated epidemic of lung cancer in women probably is only at its beginning.
In this study a direct and objective method is used to explore the relationship between exposure to tobacco smoke and lung cancer risk. There is some advantage in an approach which does not require either histories of active smokmg or histories concerning possible exposure to environmental tobacco smoke.
